Home » Topics » BioWorld Science

BioWorld Science
RSS

Shengke Pharmaceuticals discovers FLT inhibitors

March 17, 2022

NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC

March 17, 2022

LinKinVax and GTP Bioways collaborate on second-generation pan-coronavirus vaccine

March 16, 2022

Study reports insights into organ-specific aging

March 16, 2022

Satellos advances compounds to modulate muscle stem cell polarity for Duchenne muscular dystrophy

March 16, 2022

CD19/CD22 targeting bivalent CAR-T therapy show efficacy in leukemia models

March 16, 2022

Serum interleukin level changes reflect severe depression and PTSD

March 16, 2022

AbbVie and Scripps collaborate to develop direct-acting antivirals for COVID-19

March 16, 2022

Anti-IL1RAP CAN-10 antibody shows promise in the treatment of systemic sclerosis

March 16, 2022

Novel anti-inflammatory gene therapy candidates show efficacy in models of AD

March 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...